July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...
July 10, 2023 — Adona Medical, a Shifamed portfolio company that aims to deliver advanced interatrial shunting and hemod ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
June 26, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of str ...
June 26, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Teleflex and Arrow ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
June 22, 2023 — The Society of Interventional Radiology (SIR) published a new position statement offering ...
June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...
June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...
June 12, 2023 — New research published in JMIR Cardio reveals the remarkable potential of artificial intelligence (AI) ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the ...
May 30, 2023 — Twelve-month results from the SELUTION SFA trial have been presented for the first time at the Japan ...
May 30, 2023 — The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Conce ...